Malignant Mesothelioma Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2028

  • Single User License $3500

Malignant Mesothelioma Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2028

Status : March, 2023 | Pharmaceutical

Report Digest

Malignant Mesothelioma Therapeutics Market - Snapshot

The majority of firms in the global malignant mesothelioma therapeutics market are concentrating their efforts on working with organisations to research the effects of combining several medications on malignant mesothelioma. Due to the scarcity of technique patents, numerous businesses are undertaking clinical studies concentrating on diverse combinations of medications.

For example, in 2017, Boehringer Ingelheim began phase 3 of its double-blind, randomized, phase 3 study comparing Nintedanib in combination with Pemetrexed/Cisplatin followed by continuation of Nintedanib monotherapy vs. placebo in mixture with Pemetrexed/Cisplatin followed by continuation of placebo monotherapy for the treatment of mesothelioma. The expansion of the pemetrexed and combination sector is boosted by all of these efforts by the market's major competitors.

Asbestos exposure is known to trigger malignant mesothelioma, and given global regulations on asbestos usage, occurrences of mesothelioma are projected to decline in the near future. The number of malignant mesothelioma cases, on the other hand, contradicts these beliefs.

Malignant mesothelioma affects one in every 140 males and one in every 710 women, according to Cancer Research UK figures. Men are being diagnosed with malignant mesothelioma at a higher rate than women. The Pemetrexed and combination segment's revenue is increasing as a result of this reason.

One of the primary factors likely to drive use of the pemetrexed and combination medication type sector forward is the evaluation of combination treatments over monotherapy. Combination treatments, such as those that combine chemotherapy with radiotherapy, targeted antibodies, cryotherapy, or other immunotherapies, are anticipated to broaden the range of medications' possible applications.

These combination treatments also aim to significantly enhance survival rates, as evidenced by limited clinical data when compared to only surgery or radiation therapy. Various firms have discovered that tumor regulation is influenced by numerous routes, and hence attempt to adopt combination therapy as a more successful strategy. These factors are likely to work in favor of the global malignant mesothelioma therapeutics market in the forthcoming years.

Global Malignant Mesothelioma Therapeutics Market: Overview

The primary cause of malignant mesothelioma therapeutics is the prolonged exposure asbestos in the form of long thin fibers and hydrated silicates. In the recent years, there has been a considerable development in the utilization of asbestos in sectors such as transport vehicles, machines, and building materials among others. People working in the sectors that asbestos for variety of applications are at risk of exposing themselves to malignant mesothelioma and other asbestos-related disorders. However, it is not necessary that exposure to asbestos will lead to the development of malignant mesothelioma. This is due to the fact the development of this disease depends upon the duration and extent of the exposure. The growing high-risk elements are considerably contributing to the increasing need for malignant mesothelioma therapeutics. This trend is expected to continue over the course of the forecast period of 2018 to 2028 and will help in driving the growth of the global market.

Global Malignant Mesothelioma Therapeutics Market: Notable Developments

The vendor landscape of the global market is fairly fragmented due to the presence of several key players. Some of the key developments in the global malignant mesothelioma therapeutics market are given below:

  • In July 2019, Pfizer Inc. announced that the company has been successful in getting approval from the United States Food and Drug Administration about its new drug called RUXIENCE™. This drug is biosimilar to Rituxan®. This drug will be used to treat the patients suffering from the disorders such as Granulomatosis with Polyangiitis (GPA)chronic lymphocytic leukemia (CLL), and non-Hodgkin’s Lymphone (NHL) among others. The company believes that the drug has a real growth potential in delivering solid value to improve the affordability and accessibility of important treatments for cancer.
  • In July 2019, Astellas Pharma Inc. announced that the company has entered into a strategic partnership with Frequency Therapeutics Inc. Under this agreement, Astellas will develop and commercialize FX-322 outside of regions of the US.
  • In July 2019, Sanofi announced the results from the third phase of Zynquista™. These trials are for the people suffering from the type 2 diabetes and was conducted at the InSynchrony clinical program. The company announced that the phase 3 will continue without any imminent changes. The company has expressed it desire to collaborate with Lexicon to make sure the smooth transition of the research study.

Global Malignant Mesothelioma Therapeutics Market: Drivers and Restraints

Some of the key driving factors for the growth of the global malignant mesothelioma therapeutics market are listed below:

  • Increasing prevalence of the disease: This is the most common yet important factor that is driving the growth of the global malignant mesothelioma therapeutics market. People are more inclined towards the early detection of the disease and seek advanced therapeutics to cut down the overall risk of the disorder.
  • Growing awareness: Non-governmental organizations (NGOs), state-backed healthcare institutes such as hospitals and clinics are spreading large-scale awareness about malignant mesothelioma therapeutics. They are informing people about the ill effects of the disease and the ways to keep the development in check. Such initiatives are also helping to drive the growth of the global malignant mesothelioma therapeutics market.

Global Malignant Mesothelioma Therapeutics Market: Geographical Outlook

The global malignant mesothelioma therapeutics is segmented into key geographical regions such as Asia Pacific, Europe, North America, and the Rest of the World. The market is expected to be dominated by the North America region on account of increasing tolerance towards ALIMTA, and risk factors associated to the development of the disease.

The reports at TMR Research provide qualitative solutions that break the barriers of doubt or uncertainties when the stakeholders plan to expand their growth reach. The researchers compile the necessary information that enlightens the CXOs about the current growth opportunities in a specific market and enables them to make the most of the opportunities.

TMR Research is a leader in developing well-researched reports. The expertise of the researchers at TMR Research makes the report stand out from others. TMR Research reports help the stakeholders and CXOs make impactful decisions through a unique blend of innovation and analytical thinking. The use of innovation and analytical thinking while structuring a report assures complete and ideal information of the current status of the market to the stakeholders.

TMR Research has rich experience in developing state-of-the-art reports for a wide array of markets and sectors. The brilliance of the experts at TMR Research and their alacrity to conduct thorough research and create phenomenal reports makes TMR Research better than others.

5-Point Growth Formula

The 5-point growth formula developed by TMR Research provides an insight to the stakeholders and CXOs about the current situation in the market. The growth formula makes the report a perfect companion for the stakeholders and CXOs.

The 5-point growth formula includes the following points:

  • Current and Future Threats
  • Accurate Trend Analysis
  • Regional Assessment
  • Industrial Analogy
  • COVID-19 Impact

Current and Future Threats

Along with studying the opportunities necessary for growth, threats are also an important aspect to look upon for the companies and stakeholders in a specific sector. TMR Research studies every negative aspect that will hinder the growth of a specific area of business and includes it in the report. The stakeholders and CXOs will have the benefit of assessing the threat and take the necessary steps to prevent the hindrance caused due to the threats.

Accurate Trend Analysis

Keeping up with the latest trends is crucial in any business or sector. While stakeholders are aware of the trends that are on the surface, TMR Researchers find trends that are deeply entrenched in the particular market or sector. The reports are constantly updated with the latest trends so that the stakeholders and CXOs can derive benefits from the trends and generate good revenues.

Regional Assessment

Demography forms an important part of the growth pattern of all the markets. Diving deep into the demographics enables maximum output from specific areas. The TMR Research team assesses every region and picks out the vital points that have a large impact on the growth of a market.

Industrial Analogy

The analysts at TMR Research conduct an all-round analysis on the competitive landscape of the market. The observations recorded by the analysts are added to the reports so that every stakeholder gets a glimpse of the competitive scenario and frame their business plans according to the situation.

COVID-19 Impact

The COVID-19 outbreak has changed the growth projections of numerous sectors and businesses. The analysts at TMR Research have conducted a conscientious survey on the markets after the pandemic struck. The analysts have put forth their brilliant and well-researched opinions in the report. The opinions will help the stakeholders to plan their strategy accordingly.

The reports offer answers to the top 7 questions that revolve around the growth of the market

  • What are the diverse growth parameters influencing the market?
  • Which regions will contribute largely to the growth of the market
  • What are the recent innovations and technological advancements in the market?
  • What are the emerging trends across the market?
  • How has COVID-19 affected the market?
  • What will be the post-pandemic scenario of the market?
  • What are the major threats that will dent the growth prospects of the market?